ABSTRACT
Emergency contraception (EC) is the postcoital method of pregnancy prevention. Three methods of EC are used in the United States: (1) levonorgestrel-only pills, Plan B (Barr Pharmaceuticals, LLC, New Jersey) (2) combined estrogen and progestin pills, and (3) the copper intrauterine device. Used within 120 hours after unprotected sexual intercourse, EC reduces the risk of pregnancy by 60 to 94%. EC is a critical component of medical care for sexual assault survivors, and several states have laws mandating this standard of care. Levonorgestrel-only EC is available to women ≥17 years of age without a prescription. Women who were counseled by their clinician about EC were 11 times more likely to use EC in the following 12 months. Advance provision of EC to women has not been found to decrease rates of unintended pregnancy compared with routine pharmacy access; however, women routinely prefer advance provision. The newly approved by the Food and Drug Administration single-dose EC, Plan B One-Step (Barr Pharmaceuticals, LLC), may affect unintended pregnancy rates among EC users by simplifying use.
KEYWORDS
Contraception - postcoital - Plan B - levonorgestrel
REFERENCES
-
1
Finer L B, Henshaw S K.
Disparities in rates of unintended pregnancy in the United States, 1994 and 2001.
Perspect Sex Reprod Health.
2006;
38(2)
90-96
-
2
Henshaw S K.
Unintended pregnancy in the United States.
Fam Plann Perspect.
1998;
30(1)
24-29, 46
-
3
Practice Bulletin ACOG .
ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists, No. 69, December 2005 (replaces Practice Bulletin No. 25, March 2001). Emergency contraception.
Obstet Gynecol.
2005;
106(6)
1443-1452
-
4 AMA National Advisory Council on Violence and Abuse .Policy Compendium, Access to Emergency Contraception, 2008. http://Available at: www.ama.org Accessed September 15, 2009
-
5 Policy Statements ACEP. Management of the patient with the complaint of sexual assault. ACEP Policy Statements [Web site]. 2002; Policies of the national organization of emergency medicine practitioners in the United States. http://Available at: www.acep.org Accessed August 25, 2009
-
6
Harper C C, Ellertson C E.
The emergency contraceptive pill: a survey of knowledge and attitudes among students at Princeton University.
Am J Obstet Gynecol.
1995;
173(5)
1438-1445
-
7
Cheng L, Gülmezoglu A M, Piaggio G, Ezcurra E, Van Look P F.
Interventions for emergency contraception.
Cochrane Database Syst Rev.
2008;
(2)
CD001324
-
8
Ragland D, West D.
Pharmacy students' knowledge, attitudes, and behaviors regarding emergency contraception.
Am J Pharm Educ.
2009;
73(2)
26
-
9
Trussell J, Stewart F, Guest F, Hatcher R A.
Emergency contraceptive pills: a simple proposal to reduce unintended pregnancies.
Fam Plann Perspect.
1992;
24(6)
269-273
-
10
Van Look P F, von Hertzen H.
Clinical uses of antiprogestogens.
Hum Reprod Update.
1995;
1(1)
19-34
-
11
Haddad L B, Nour N M.
Unsafe abortion: unnecessary maternal mortality.
Rev Obstet Gynecol.
2009;
2(2)
122-126
-
12
Singh S.
Hospital admissions resulting from unsafe abortion: estimates from 13 developing countries.
Lancet.
2006;
368(9550)
1887-1892
-
13 Governments worldwide put emergency contraception into women's hands; 2004. http://Available at: www.reproductiverights.org Accessed September 15, 2009
-
14
Glasier A.
Emergency postcoital contraception.
N Engl J Med.
1997;
337(15)
1058-1064
-
15 Stewart F, Trussell J, Van Look P FA. Emergency contraception. In: Contraceptive Technology. 19th ed. New York, NY; Ardent Media 2008: 87-109
-
16
Ellertson C, Trussell J, Stewart F, Koenig J, Raymond E G, Shochet T.
Emergency contraception.
Semin Reprod Med.
2001;
19(4)
323-330
-
17
Morris J M, Van Wagenen G.
Compounds interfering with ovum implantation and development. 3. The role of estrogens.
Am J Obstet Gynecol.
1966;
96(6)
804-815
-
18
Yuzpe A A, Thurlow H J, Ramzy I, Leyshon J I.
Post coital contraception—a pilot study.
J Reprod Med.
1974;
13(2)
53-58
-
19 FDA approves generic prescription-only version of Plan B emergency contraceptive for women ages 17 and under; 2009. http://Available at: www.fda.gov/newsevents Accessed August 27, 2009
-
20
Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Task Force on Postovulatory Methods of Fertility Regulation.
Lancet.
1998;
352(9126)
428-433
-
21 Reports OPRR. Protection of Human Subjects. Code of Federal Regulations 45 CFR 46. National Institutes of Health 1983
-
22 Hughes E C. Committee on Terminology of the American College of Obstetricians and Gynecologists .Obstetric-Gynecologic Terminology. Philadelphia, PA; F.A. Davis 1972
-
23
Durand M, del Carmen Cravioto M, Raymond E G et al..
On the mechanisms of action of short-term levonorgestrel administration in emergency contraception.
Contraception.
2001;
64(4)
227-234
-
24
Hapangama D, Glasier A F, Baird D T.
The effects of peri-ovulatory administration of levonorgestrel on the menstrual cycle.
Contraception.
2001;
63(3)
123-129
-
25
Marions L, Hultenby K, Lindell I, Sun X, Ståbi B, Gemzell Danielsson K.
Emergency contraception with mifepristone and levonorgestrel: mechanism of action.
Obstet Gynecol.
2002;
100(1)
65-71
-
26
Marions L, Cekan S Z, Bygdeman M, Gemzell-Danielsson K.
Effect of emergency contraception with levonorgestrel or mifepristone on ovarian function.
Contraception.
2004;
69(5)
373-377
-
27
Trussell J, Ellertson C, von Hertzen H et al..
Estimating the effectiveness of emergency contraceptive pills.
Contraception.
2003;
67(4)
259-265
-
28
Wilcox A J, Weinberg C R, Baird D D.
Timing of sexual intercourse in relation to ovulation. Effects on the probability of conception, survival of the pregnancy, and sex of the baby.
N Engl J Med.
1995;
333(23)
1517-1521
-
29
Trussell J, Raymond E G.
Statistical evidence about the mechanism of action of the Yuzpe regimen of emergency contraception.
Obstet Gynecol.
1999;
93(5 Pt 2)
872-876
-
30
Raymond E G, Lovely L P, Chen-Mok M, Seppälä M, Kurman R J, Lessey B A.
Effect of the Yuzpe regimen of emergency contraception on markers of endometrial receptivity.
Hum Reprod.
2000;
15(11)
2351-2355
-
31
Taskin O, Brown R W, Young D C, Poindexter A N, Wiehle R D.
High doses of oral contraceptives do not alter endometrial alpha 1 and alpha v beta 3 integrins in the late implantation window.
Fertil Steril.
1994;
61(5)
850-855
-
32
Hansen L B, Saseen J J, Teal S B.
Levonorgestrel-only dosing strategies for emergency contraception.
Pharmacotherapy.
2007;
27(2)
278-284
-
33
Kunz G, Beil D, Deininger H, Wildt L, Leyendecker G.
The dynamics of rapid sperm transport through the female genital tract: evidence from vaginal sonography of uterine peristalsis and hysterosalpingoscintigraphy.
Hum Reprod.
1996;
11(3)
627-632
-
34
Kesserü E, Garmendia F, Westphal N, Parada J.
The hormonal and peripheral effects of d-norgestrel in postcoital contraception.
Contraception.
1974;
10(4)
411-424
-
35
Hamoda H, Ashok P W, Stalder C, Flett G M, Kennedy E, Templeton A.
A randomized trial of mifepristone (10 mg) and levonorgestrel for emergency contraception.
Obstet Gynecol.
2004;
104(6)
1307-1313
-
36
von Hertzen H, Piaggio G, Ding J WHO Research Group on Post-ovulatory Methods of Fertility Regulation et al.
Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial.
Lancet.
2002;
360(9348)
1803-1810
-
37
Ngai S W, Fan S, Li S et al..
A randomized trial to compare 24 h versus 12 h double dose regimen of levonorgestrel for emergency contraception.
Hum Reprod.
2005;
20(1)
307-311
-
38
Fincham J E, Harris C E, Fassett W E, Richards W.
Over-the-counter availability of Plan B emergency contraception: further discussion and commentary.
Ann Pharmacother.
2005;
39(2)
346-351
-
39 State Policies in Brief .Emergency contraception. State policies in brief. Description of state laws and policies regarding emergency contraception in the United States. http://Available at: www.guttmacher.org Accessed August 25, 2009
-
40 Plan B. OneStep Prescribing Information; 2009. http://Available at: www.accessdata.fda.gov/drugsatfda_docs/label/2009/021998lbl.pdf Accessed October 16, 2009
-
41 ACOG statement on Single-Dose EC Reformulation. 2009. http://Available at: www.acog.org/from_home/publications/press_releases/nr07-15-09.cfm Accessed October 15, 2009
-
42
Ho P C, Kwan M S.
A prospective randomized comparison of levonorgestrel with the Yuzpe regimen in post-coital contraception.
Hum Reprod.
1993;
8(3)
389-392
-
43
Arowojolu A O, Okewole I A, Adekunle A O.
Comparative evaluation of the effectiveness and safety of two regimens of levonorgestrel for emergency contraception in Nigerians.
Contraception.
2002;
66(4)
269-273
-
44
Devoto L, Fuentes A, Palomino A et al..
Pharmacokinetics and endometrial tissue levels of levonorgestrel after administration of a single 1.5-mg dose by the oral and vaginal route.
Fertil Steril.
2005;
84(1)
46-51
-
45
Yuzpe A A, Lancee W J.
Ethinylestradiol and dl-norgestrel as a postcoital contraceptive.
Fertil Steril.
1977;
28(9)
932-936
-
46
Van Santen M R, Haspels A A.
Interception II: postcoital low-dose estrogens and norgestrel combination in 633 women.
Contraception.
1985;
31(3)
275-293
-
47
Percival-Smith R K, Abercrombie B.
Postcoital contraception with dl-norgestrel/ethinyl estradiol combination: six years experience in a student medical clinic.
Contraception.
1987;
36(3)
287-293
-
48
Rodrigues I, Grou F, Joly J.
Effectiveness of emergency contraceptive pills between 72 and 120 hours after unprotected sexual intercourse.
Am J Obstet Gynecol.
2001;
184(4)
531-537
-
49
First emergency contraceptive product hits U.S. market shelves.
Contracept Technol Update.
1998;
19(11)
141-143
-
50 And then there was one: Barr withdraws Preven. Contraceptive Technology Update, Executive Summary; 2004. http://Available at: www.accessmylibrary.com/article/print/1G1-120976676 Accessed September 9, 2009
-
51
Trussell J, Rodríguez G, Ellertson C.
New estimates of the effectiveness of the Yuzpe regimen of emergency contraception.
Contraception.
1998;
57(6)
363-369
-
52
Trussell J, Rodríguez G, Ellertson C.
Updated estimates of the effectiveness of the Yuzpe regimen of emergency contraception.
Contraception.
1999;
59(3)
147-151
-
53
Ragan R E, Rock R W, Buck H W.
Metoclopramide pretreatment attenuates emergency contraceptive-associated nausea.
Am J Obstet Gynecol.
2003;
188(2)
330-333
-
54 Emergency Contraception .2005. http://Available at: www.who.int/mediacentre/factsheets/fs244/en/print.html Accessed September 15, 2009
-
55
Prescription drug products: certain combined oral contraceptives for use as postcoital emergency contraception.
Fed Regist.
1997;
62
8609
-
56
Webb A, Taberner D.
Clotting factors after emergency contraception.
Adv Contracept.
1993;
9(1)
75-82
-
57
Balter M.
Profile. For ‘father’ of abortion drug, vindication at last.
Science.
2000;
290(5489)
39
-
58
Gemzell-Danielsson K, Marions L.
Mechanisms of action of mifepristone and levonorgestrel when used for emergency contraception.
Hum Reprod Update.
2004;
10(4)
341-348
-
59
Rowlands S.
New technologies in contraception.
BJOG.
2009;
116(2)
230-239
-
60
Comparison of three single doses of mifepristone as emergency contraception: a randomised trial. Task Force on Postovulatory Methods of Fertility Regulation.
Lancet.
1999;
353(9154)
697-702
-
61
Lippes J, Malik T, Tatum H J.
The postcoital copper-T.
Adv Plan Parent.
1976;
11(1)
24-29
-
62
Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit .
FFPRHC Guidance: Emergency contraception (April 2003).
J Fam Plann Reprod Health Care.
2003;
29(2)
9-16
-
63
Grimes D A, Schulz K F.
Antibiotic prophylaxis for intrauterine contraceptive device insertion.
Cochrane Database Syst Rev.
2001;
(2)
CD001327
-
64
Penney G, Brechin S, de Souza A Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit et al.
FFPRHC Guidance (January 2004). The copper intrauterine device as long-term contraception.
J Fam Plann Reprod Health Care.
2004;
30(1)
29-41, quiz 42
-
65
Segal S J, Alvarez-Sanchez F, Adejuwon C A, Brache de Mejia V, Leon P, Faundes A.
Absence of chorionic gonadotropin in sera of women who use intrauterine devices.
Fertil Steril.
1985;
44(2)
214-218
-
66
Stanford J B, Mikolajczyk R T.
Mechanisms of action of intrauterine devices: update and estimation of postfertilization effects.
Am J Obstet Gynecol.
2002;
187(6)
1699-1708
-
67
Askalani A H, Al-Senity A M, Al-Agizy H M, Salam H I, Al-Masry G I, El-Sadek S M.
Evaluation of copper T-200 as a post-coital contraceptive.
Egyptian J Obstet Gynecol.
1987;
13
63-66
-
68
Trussell J.
Contraceptive efficacy.
Arch Dermatol.
1995;
131(9)
1064-1068
-
69
Grimes D A, Lopez L M, Manion C, Schulz K F.
Cochrane systematic reviews of IUD trials: lessons learned.
Contraception.
2007;
75(6, suppl)
S55-S59
-
70 Criminal Victimization in the United States—Statistical Tables .Data from National Crime Victimization Survey presented in tables. http://Available at: www.ojp.usdoj.gov/bjs/abstract/cvusst.htm Accessed September 17, 2009
-
71
Kaplan D W, Feinstein R A, Fisher M M Committee on Adolescence et al.
Care of the adolescent sexual assault victim.
Pediatrics.
2001;
107(6)
1476-1479
-
72
Kavanaugh M L, Saladino R A, Gold M A.
Emergency contraception services for adolescents: a National Survey of Children's Hospital Emergency Department Directors.
J Pediatr Adolesc Gynecol.
2009;
22(2)
111-119
-
73
Patel A, Panchal H, Piotrowski Z H, Patel D.
Comprehensive medical care for victims of sexual assault: a survey of Illinois hospital emergency departments.
Contraception.
2008;
77(6)
426-430
-
74
Espey E, Ogburn T, Leeman L, Buchen E, Angeli E, Qualls C.
Compliance with mandated emergency contraception in New Mexico emergency departments.
J Womens Health (Larchmt).
2009;
18(5)
619-623
-
75
Rosenberg K D, Demunter J K, Liu J.
Emergency contraception in emergency departments in Oregon, 2003.
Am J Public Health.
2005;
95(8)
1453-1457
-
76
Woodell A T, Bowling J M, Moracco K E, Reed M L.
Emergency contraception for sexual assault victims in North Carolina emergency departments.
N C Med J.
2007;
68(6)
399-403
-
77 Emergency contraception for rape survivors; 2007. Available at: http://reproductiverights.org/en/document/emergency-contraception-for-rape-survivors Accessed September 17, 2009
-
78 Committee for medicinal products for human use summary of positive opinion for Ellaone Doc.Ref.EMEA/CHMP/167750/2009. http://Available at: www.emea.europa.eu Accessed September 16, 2009
-
79 International Consortium for Emergency Contraception .2009. http://Available at: www.cecinfo.org/inidex.php Accessed September 16, 2009
-
80
Creinin M D, Schlaff W, Archer D F et al..
Progesterone receptor modulator for emergency contraception: a randomized controlled trial.
Obstet Gynecol.
2006;
108(5)
1089-1097
-
81
Polis C B, Schaffer K, Blanchard K, Glasier A, Harper C C, Grimes D A.
Advance provision of emergency contraception for pregnancy prevention (full review).
Cochrane Database Syst Rev.
2007;
(2)
CD005497
-
82 National Survey of Women About Their Sexual Health: Take charge of your sexual health. 2003. Available at: http://www.kff.org/womenshealth/3341-index.cfm Accessed September 15, 2009
-
83
Kavanaugh M L, Schwarz E B.
Counseling about and use of emergency contraception in the United States.
Perspect Sex Reprod Health.
2008;
40(2)
81-86
-
84
Rocca C H, Schwarz E B, Stewart F H, Darney P D, Raine T R, Harper C C.
Beyond access: acceptability, use and nonuse of emergency contraception among young women.
Am J Obstet Gynecol.
2007;
196(1)
21-26
-
85
Raymond E G, Trussell J, Polis C B.
Population effect of increased access to emergency contraceptive pills: a systematic review.
Obstet Gynecol.
2007;
109(1)
181-188
-
86 Brown S S, Eisenberg L. Institute of Medicine .(U.S.) Committee on Unintended Pregnancy. The Best Intentions: Unintended Pregnancy and the Well-Being of Children and Families. Washington, DC; National Academy Press 1995
-
87
Turok D K, Simonsen S E, Marshall N.
Trends in levonorgestrel emergency contraception use, births, and abortions: the Utah experience.
Medscape J Med.
2009;
11(1)
30
-
88 Paraguard Product Information .Pharmaceutical product commercial Web site. http://Available at: www.paraguard.com Accessed September 16, 2009
Aileen LangstonM.D.
Clinical Instructor, Department of Obstetrics and Gynecology, Columbia University Medical Center
622 West 168th Street, PH 1669, New York, NY 10032
Email: al2632@columbia.edu
